Kezar Life Sciences Stock Analysis

KZR Stock  USD 6.48  0.05  0.78%   
Kezar Life Sciences is undervalued with Real Value of 8.1 and Target Price of 13.5. The main objective of Kezar Life stock analysis is to determine its intrinsic value, which is an estimate of what Kezar Life Sciences is worth, separate from its market price. There are two main types of Kezar Life's stock analysis: fundamental analysis and technical analysis.
The Kezar Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kezar Life is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Kezar Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Kezar Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kezar Life Sciences recorded a loss per share of 13.12. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 30th of October 2024. Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company was incorporated in 2015 and is based in South San Francisco, California. Kezar Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To find out more about Kezar Life Sciences contact the company at 650 822 5600 or learn more at https://www.kezarlifesciences.com.

Kezar Life Sciences Investment Alerts

Kezar Life Sciences generated a negative expected return over the last 90 days
Kezar Life Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 7 M. Reported Net Loss for the year was (101.87 M) with loss before taxes, overhead, and interest of (72.85 M).
Kezar Life Sciences has about 306.84 M in cash with (81.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49.
Kezar Life Sciences has a frail financial position based on the latest SEC disclosures
Roughly 64.0% of the company shares are owned by institutional investors
Latest headline from stockhead.com.au: Resources Top 6 Gold explorers look for proof in the pudding as prices get drill rigs moving

Kezar Life Sciences Upcoming and Recent Events

12th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Kezar Largest EPS Surprises

Earnings surprises can significantly impact Kezar Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-14
2022-12-31-0.28-0.250.0310 
2020-08-05
2020-06-30-0.26-0.220.0415 
2024-08-13
2024-06-30-0.32-0.270.0515 
View All Earnings Estimates

Kezar Life Environmental, Social, and Governance (ESG) Scores

Kezar Life's ESG score is a quantitative measure that evaluates Kezar Life's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Kezar Life's operations that may have significant financial implications and affect Kezar Life's stock price as well as guide investors towards more socially responsible investments.

Kezar Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Acuitas Investments, Llc2024-06-30
986.8 K
Ikarian Capital, Llc2024-06-30
869 K
Blackrock Inc2024-06-30
830.4 K
Qiming U.s. Ventures Management, Llc2024-06-30
828.7 K
Renaissance Technologies Corp2024-06-30
778.5 K
Millennium Management Llc2024-06-30
628.5 K
Jane Street Group Llc2024-06-30
549.1 K
Geode Capital Management, Llc2024-06-30
545.2 K
Citadel Advisors Llc2024-06-30
483.2 K
Suvretta Capital Management, Llc2024-06-30
7.2 M
Avidity Partners Management Lp2024-06-30
M
Note, although Kezar Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Kezar Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 47.28 M.

Kezar Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.41)(0.44)
Return On Capital Employed(0.47)(0.49)
Return On Assets(0.41)(0.44)
Return On Equity(0.62)(0.59)

Management Efficiency

Kezar Life Sciences has Return on Asset of (0.2807) % which means that on every $100 spent on assets, it lost $0.2807. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5148) %, meaning that it generated no profit with money invested by stockholders. Kezar Life's management efficiency ratios could be used to measure how well Kezar Life manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/01/2025, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.49. At this time, Kezar Life's Net Tangible Assets are relatively stable compared to the past year. As of 02/01/2025, Non Current Assets Total is likely to grow to about 17.2 M, while Other Current Assets are likely to drop slightly above 3.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.33  2.49 
Tangible Book Value Per Share 2.33  2.49 
Enterprise Value Over EBITDA(6.08)(6.38)
Price Book Value Ratio 3.30  3.46 
Enterprise Value Multiple(6.08)(6.38)
Price Fair Value 3.30  3.46 
Enterprise Value771.1 M732.5 M
Evaluating the management effectiveness of Kezar Life allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Kezar Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(14.22)
Beta
0.217
Return On Assets
(0.28)
Return On Equity
(0.51)

Technical Drivers

As of the 1st of February, Kezar Life secures the Standard Deviation of 2.56, mean deviation of 1.85, and Risk Adjusted Performance of (0.09). Kezar Life Sciences technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kezar Life Sciences risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Kezar Life Sciences is priced some-what accurately, providing market reflects its recent price of 6.48 per share. Given that Kezar Life Sciences has information ratio of (0.15), we recommend you to check Kezar Life's last-minute market performance to make sure the company can sustain itself at a future point.

Kezar Life Sciences Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Kezar Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Kezar Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Kezar Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kezar Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kezar Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kezar Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Kezar Life Outstanding Bonds

Kezar Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kezar Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kezar bonds can be classified according to their maturity, which is the date when Kezar Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Kezar Life Predictive Daily Indicators

Kezar Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kezar Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Kezar Life Corporate Filings

16th of January 2025
Other Reports
ViewVerify
F4
13th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
10th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
3rd of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of November 2024
Other Reports
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
29th of October 2024
Other Reports
ViewVerify
8K
28th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Kezar Life Forecast Models

Kezar Life's time-series forecasting models are one of many Kezar Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kezar Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Kezar Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kezar Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kezar shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kezar Life. By using and applying Kezar Stock analysis, traders can create a robust methodology for identifying Kezar entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(13.10)(13.75)
Operating Profit Margin(13.53)(14.21)
Net Loss(13.10)(13.75)
Gross Profit Margin 0.76  0.68 

Current Kezar Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kezar analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kezar analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
13.5Buy6Odds
Kezar Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Kezar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kezar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kezar Life Sciences, talking to its executives and customers, or listening to Kezar conference calls.
Kezar Analyst Advice Details

Kezar Stock Analysis Indicators

Kezar Life Sciences stock analysis indicators help investors evaluate how Kezar Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Kezar Life shares will generate the highest return on investment. By understating and applying Kezar Life stock analysis, traders can identify Kezar Life position entry and exit signals to maximize returns.
Begin Period Cash Flow40.5 M
Long Term Debt10.1 M
Common Stock Shares Outstanding72.6 M
Total Stockholder Equity187.6 M
Property Plant And Equipment Net8.7 M
Cash And Short Term Investments201.4 M
Cash35.5 M
Accounts Payable8.3 M
Net Debt-16.6 M
50 Day M A6.8002
Total Current Liabilities17.7 M
Other Operating Expenses112.2 M
Non Current Assets Total14.3 M
Non Currrent Assets Other5.6 M
Stock Based Compensation18.1 M

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.